End-of-life planning and its relevance for patients' and oncologists' decisions in choosing cancer therapy

Cancer

Volumn 113, Issue 12 SUPPL., 2008, Pages 3540-3547

  Saraiya, Biren ^a   Bodnar Deren, Susan ^b   Leventhal, Elaine ^c   Leventhal, Howard ^b  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Advance directive; End of life planning; Palliative care; Patient physician communication

Indexed keywords

ADVANCED CANCER; BEHAVIORAL SCIENCE; CANCER DIAGNOSIS; CANCER THERAPY; CLINICAL PRACTICE; CONFERENCE PAPER; DECISION MAKING; FINANCIAL MANAGEMENT; GERIATRIC PATIENT; HEALTH CARE; HOSPICE CARE; HUMAN; INTERPERSONAL COMMUNICATION; LIFESPAN; LIVING WILL; ONCOLOGY; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; TERMINAL CARE; TREATMENT PLANNING;

DECISION MAKING; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT CARE PLANNING; PHYSICIAN'S ROLE; TERMINAL CARE;

EID: 59449101634     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23946     Document Type: Conference Paper

References (37)

1. US Cancer Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality. Atlanta, Ga: US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2007.
2. Jemal A, Clegg LX, Ward E, et al. Annual Report to the Nation on the Status of Cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
3. National Heart, Lung, and Blood Institute. Fact Book, Fiscal Year 2006. Bethesda, Md: US Department of Health and Human Services, National Heart, Lung, and Blood Institute; 2007.
4. Miksad RA, Schnipper L, Goldstein M. Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value? J Clin Oncol. 2007;25:4506-4507.
5. Yabroff KR, Davis WW, Lamont EB, et al. Patient time costs associated with cancer care. J Natl Cancer Inst. 2007;99:14-23.
6. US Congress. Patient Self-Determination Act of 1990 of the Omnibus Reconciliation Act of 1990: Public Law 101-508. Washington, DC: US Congress; November 5, 1990.
7. Uniform Law Commissioners. Uniform Health Care Decisions Act. Chicago, Ill: National Conference of Commissioners on Uniform State Laws; 1994.
8. Field M, Cassel C. Approaching Death. Washington, DC: National Academies Press; 1997.
9. Singer PA, Martin DK, Lavery JV, Thiel EC, Kelner M, Mendelssohn DC. Reconceptualizing advance care planning from the patient's perspective. Arch Intern Med. 1998;158: 879-884.
10. Galambos CM. Preserving end-of-life autonomy: the Patient Self-Determination Act and the Uniform Health Care Decisions Act. Health Soc Work. 1998;23:275-281.
11. Degenholtz HB, Rhee Y, Arnold RM. Brief communication: the relationship between having a living will and dying in place. Ann Intern Med. 2004;141:113-117.
12. Teno J, Lynn J, Wenger N, et al. Advance directives for seriously ill hospitalized patients: effectiveness with the patient self-determination act and the SUPPORT intervention. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc. 1997;45:500-507.
13. Kass-Bartelmes BL, Hughes R. Advance care planning: preferences for care at the end of life. J Pain Palliat Care Pharmacother. 2004;18:87-109.
14. Waters CM. End-of-life care directives among African Americans: lessons learned-a need for community-centered discussion and education. J Commun Health Nurs. 2000;17:25-37.
15. Degenholtz HB, Arnold RA, Meisel A, Lave JR. Persistence of racial disparities in advance care plan documents among nursing home residents. J Am Geriatr Soc. 2002;50: 378-381.
16. Robert Wood Johnson Foundation. Last Acts. Means to a Better End: A Report on Dying in America Today. Princeton, NJ: Robert Wood Johnson Foundation; 2002.
17. Teno JM, Gruneir A, Schwartz Z, Nanda A, Wetle T. Association between advance directives and quality of end-of- life care: a national study. J Am Geriatr Soc. 2007;55:189-194.
18. Later EB, King D. Advance directives: results of a community education symposium. Crit Care Nurse. 2007;27:31-35; quiz 36.
19. Lamont EB, Siegler M. Paradoxes in cancer patients' advance care planning. J Palliat Med. 2000;3:27-35.
20. Ditto PH, Hawkins NA. Advance directives and cancer decision making near the end of life. Health Psychol. 2005;24(4suppl):S63-S70.
21. Hawkins NA, Ditto PH, Danks JH, Smucker WD. Micromanaging death: process preferences, values, and goals in end-of-life medical decision making. Gerontologist. 2005; 45:107-117.
22. Balmer CE, Thomas P, Osborne RJ. Who wants second-line, palliative chemotherapy? Psychooncology. 2001;10:410-418.
23. Hirose T, Horichi N, Ohmori T, et al. Patients preferences in chemotherapy for advanced nonsmall-cell lung cancer. Intern Med. 2005;44:107-113.
24. Loewenstein G. Hot-cold empathy gaps and medical decision making. Health Psychol. 2005;24(4 suppl):S49-S56.
25. Ditto PH, Jacobson JA, Smucker WD, Danks JH, Fagerlin A. Context changes choices: a prospective study of the effects of hospitalization on life-sustaining treatment preferences. Med Decis Making. 2006;26:313-322.
26. Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. JClin Oncol. 2007;25:1960-1966.
27. Horstmann E, McCabe MS, Grochow L, et al. Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med. 2005;352:895-904.
28. Bakitas M, Ahles TA, Skalla K, et al; ENABLE Project Team. Proxy perspectives regarding end-of-life care for persons with cancer. Cancer. 2008;112:1854-1861.
29. Lamont EB, Christakis NA. Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med. 2001;134:1096-1105.
30. Fried TR, O'Leary J, Van Ness P Fraenkel L. Inconsistency over time in the preferences of older persons with advanced illness for life-sustaining treatment. J Am Geriatr Soc. 2007;55:1007-1014.
31. Leventhal H, Weinman J, Leventhal EA, Phillips LA. Health psychology: the search for pathways between behavior and health. Annu Rev Psychol. 2008;59:477-505.
32. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000;35: 181-200.
33. Johnson JE, Leventhal H. Effects of accurate expectations and behavioral instructions on reactions during a noxious medical examination. J Pers Soc Psychol. 1974;29:710-718.
34. Johnson JE, Morrissey JF, Leventhal H. Psychological preparation for an endoscopic examination. Gastrointest Endosc. 1973;19:180-182.
35. Chapman GB. Short-term cost for long-term benefit: time preference and cancer control. Health Psychol. 2005;24(4suppl):S41-S48.
36. Back AL, Arnold RM, Baile WF, et al. Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med. 2007;167: 453-460.
37. Leventhal H, Musumeci TJ, Contrada RJ. Current issues and new directions in psychology and health: theory, translation, and evidence-based practice. Psychol Health. 2007; 22:381-386.